Latest Lactams Stories
OTTAWA, Feb. 22, 2013 /CNW/ - The issue: Two unauthorized health products "18 Again" and "Stiff 4 Hours" were tested by Health Canada and were found to contain hidden ingredients (sildenafil or tadalafil) that may pose serious risks to the health of Canadians. The products were being sold at the Unchained Romance booth at the 12(th) Annual Vancouver Taboo Sex Show. These products are promoted as male sexual stimulants and contain hidden prescription medications. Approved...
OTTAWA, Feb. 18, 2013 /CNW/ - The issue: A Toronto retail outlet (Handy Variety, 591 Sherbourne St.) has voluntarily handed over counterfeit Viagra and Cialis to Health Canada following a compliance and enforcement action by the Department. The counterfeit Viagra product is labelled as 100mg tablets (lot number 314833021), and has 11 blister packs of 4 tablets and one incomplete blister of 2 tablets per package. The counterfeit Cialis product is labelled as 20mg tablets (lot...
The Firm is currently evaluating Propecia lawsuits on behalf of men who suffered persistent sexual dysfunction allegedly due to Propecia. New York, NY (PRWEB) February 17, 2013 Propecia lawsuits continue to move forward in a consolidated litigation underway in New Jersey Superior Court, Middlesex County, Bernstein Liebhard LLP reports. According to court records, the next Status Conference in the New Jersey Propecia litigation has been scheduled for March 7, 2013 at 10:00 a.m. There are...
Michael Harper for redOrbit.com – Your Universe Online Ecosystems are complicated and tightly integrated systems. One small change to any part of the system can and will affect another part of the system further down the line. As humans, it’s sometimes easy to forget that we’re also a part of a larger ecosystem and that even the tiniest of actions can affect another living thing somewhere down the line. A recent study describes this sort of cause and effect chain reaction, finding...
SAN DIEGO, Feb. 11, 2013 /PRNewswire/ -- MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today the appointment of Thomas C. Reynolds, M.D., Ph.D., to its Board of Directors. A biotechnology industry veteran, Dr. Reynolds joins the Board with more than 20 years of oncology drug development experience, including direct oversight in the development and approval of the hematologic cancer drug ADCETRIS(®)....
Dr. Reddy's Laboratories Ltd. announced recently that it has started selling the generic form of the anti-hair loss drug Propecia. According to a Jan. 3 news report in Fox News, sale of finasteride 1 mg tablets, that are a copycat version of Merck's Propecia, is expected to boost the Indian generic drug maker's profits. Newport Beach, CA (PRWEB) February 02, 2013 Dr. Reddy's Laboratories announced that it has begun sales of a generic form of anti-hair loss drug Propecia in...
LOS ANGELES, Jan. 30, 2013 /PRNewswire/ -- Since sexuality is such an important part of who we are, men will always seek out effective erectile dysfunction remedies. So, it's no surprise that such massively marketed and potentially dangerous pharmaceuticals as Viagra and Cialis have generated an awful lot of attention -- as well as plenty of cold, hard cash -- for the big drug companies. Fortunately, the search for effective erectile dysfunction natural remedies mounted by the...
OTTAWA, Jan. 8, 2013 /CNW/ - Health Canada today released the January 2013 issue of the Canadian Adverse Reaction Newsletter (CARN). Articles in this issue provide information and guidance to health care professionals on: the risk of convulsions suspected of being associated with the oral laxative Pico-Salax and other products containing sodium picosulfate/magnesium citrate; the antipsychotic drug risperidone and its suspected association with muscle damage independent of...
CUPERTINO, Calif., Jan. 3, 2013 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) announced that its licensee, Zogenix Inc. (Nasdaq: ZGNX), today reported positive single-dose pharmacokinetic (PK) results from the Phase 1 clinical trial of Relday((TM)), an investigational candidate of a proprietary, once-monthly subcutaneous formulation of risperidone for the treatment of schizophrenia. According to Zogenix, adverse events in the Phase 1 trial in patients diagnosed with schizophrenia...
According to court documents, on December 6th, 2012, a Texas resident and his wife filed a lawsuit in Pennsylvania Eastern District Court alleging he developed prostate cancer from his use of the drug Avodart. In light of these news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Avodart side effects. San Diego, CA (PRWEB) December 31, 2012 AttorneyOne.com, a...
